SOBR Safe Inc. has reported its financial and operating results for the first quarter ended March 31, 2025. The company experienced a significant 80.5% increase in total revenue, reaching $86.6 thousand compared to $48.0 thousand in the same period of 2024. The net loss improved to $1.9 million from $2.5 million in the first quarter of 2024. The company's gross margin rose to 58.8%, up from 48.4% in the previous year. Operating expenses increased to $2.0 million from $1.7 million due to higher general and administrative costs related to a growing employee headcount, partly offset by reduced third-party professional service fees. SOBR Safe Inc. deployed 148 SOBRsureTM devices in the first quarter, marking a 41.0% increase compared to December 31, 2024. The company also enhanced its patent-pending software technology with updates to its mobile application, which included improved administrative tools, upgraded notification protocols, and a redesigned user interface. Additionally, the company added Dr. Benjamin Sanchez as a Scientific Advisor to explore non-dilutive federal funding, licensing opportunities, and clinical research partnerships. Cash and cash equivalents stood at $10.1 million at the end of the first quarter, up from $8.4 million at the end of 2024, bolstered by approximately $3.3 million in net proceeds from the exercise of outstanding warrants.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。